Find participating medical centers and current study status in each of them

    Find participating medical centers

    A study to evaluate the use of a fixed-dose combination of pertuzumab and trastuzumab given as an injection under the skin for treating people with HER2-positive early breast cancer

    • Cancer
    • Breast Cancer
    • HER2-positive Early Breast Cancer